{"doi":"10.1101/2023.12.05.23299462","title":"SARS-CoV-2 Humoral Immune Responses in Convalescent Individuals Over 12 Months Reveal Severity-Dependent Antibody Dynamics","abstract":"Background: Understanding the kinetics and longevity of antibody responses to SARS-CoV-2 is critical to informing strategies toward reducing Coronavirus disease 2019 (COVID-19) reinfections, and improving vaccination and therapy approaches. Methods: We evaluated antibody titers against SARS-CoV-2 nucleocapsid (N), spike (S), and receptor binding domain (RBD) of spike in 98 convalescent participants who experienced asymptomatic, mild, moderate or severe COVID-19 disease and in 17 non-vaccinated, non-infected controls, using four different antibody assays. Participants were sampled longitudinally at 1, 3, 6, and 12 months post-SARS-CoV-2 positive PCR test. Findings: Increasing acute COVID-19 disease severity correlated with higher anti-N and anti-RBD antibody titers throughout 12 months post-infection. Anti-N and anti-RBD titers declined over time in all participants, with the exception of increased anti-RBD titers post-vaccination, and the decay rates were faster in hospitalized compared to non-hospitalized participants. <50% of participants retained anti-N titers above control levels at 12 months, with non-hospitalized participants falling below control levels sooner. Nearly all hospitalized and non-hospitalized participants maintained anti-RBD titers above controls for up to 12 months, suggesting longevity of protection against severe reinfections. Nonetheless, by 6 months, few participants retained >50% of their 1-month anti-N or anti-RBD titers. Vaccine-induced increases in anti-RBD titers were greater in non-hospitalized relative to hospitalized participants. Early convalescent antibody titers correlated with age, but no association was observed between Post-Acute Sequelae of SARS-CoV-2 infection (PASC) status or acute steroid treatment and convalescent antibody titers. Interpretation: Hospitalized participants developed higher anti-SARS-CoV-2 antibody titers relative to non-hospitalized participants, a difference that persisted throughout 12 months, despite the faster decline in titers in hospitalized participants. In both groups, while anti-N titers fell below control levels for at least half of the participants, anti-RBD titers remained above control levels for almost all participants over 12 months, demonstrating generation of long-lived antibody responses known to correlate with protection from severe disease across COVID-19 severities. Overall, our findings contribute to the evolving understanding of COVID-19 antibody dynamics. Funding: Austin Public Health, NIAAA, Babson Diagnostics, Dell Medical School Startup.","journal":"medRxiv","year":2023,"id":414723,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":0,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9596,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2023-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1196337,"name":"Maisey Schuler","orcid":"0009-0007-0461-6151","position":1,"is_corresponding":false},{"id":1029460,"name":"Cole Maguire","orcid":"0000-0001-8986-9762","position":2,"is_corresponding":false},{"id":105931,"name":"Dzifa Amengor","orcid":"0000-0001-5705-3259","position":3,"is_corresponding":false},{"id":105929,"name":"Annalee W. Nguyen","orcid":"0000-0003-1268-7164","position":4,"is_corresponding":false},{"id":1196338,"name":"Rebecca Wilen","orcid":"0000-0002-8895-0339","position":5,"is_corresponding":false},{"id":1196645,"name":"Jacob E. Rogers","orcid":null,"position":6,"is_corresponding":false},{"id":1172927,"name":"Sam Bazzi","orcid":"0000-0001-5951-9243","position":7,"is_corresponding":false},{"id":1196339,"name":"Blaine Caslin","orcid":"0000-0002-4658-2945","position":8,"is_corresponding":false},{"id":1196646,"name":"Christopher DiPasquale","orcid":null,"position":9,"is_corresponding":false},{"id":1196647,"name":"Melissa Abigania","orcid":null,"position":10,"is_corresponding":false},{"id":225271,"name":"Eric N. Olson","orcid":"0000-0003-1151-8262","position":11,"is_corresponding":false},{"id":1196648,"name":"Janelle Creaturo","orcid":null,"position":12,"is_corresponding":false},{"id":1030168,"name":"Kerin Hurley","orcid":null,"position":13,"is_corresponding":false},{"id":582272,"name":"Todd Triplett","orcid":"0000-0001-5494-6510","position":14,"is_corresponding":false},{"id":59496,"name":"Justin F. Rousseau","orcid":"0000-0002-2817-9124","position":15,"is_corresponding":false},{"id":426303,"name":"Stephen M. Strakowski","orcid":"0000-0003-2837-6280","position":16,"is_corresponding":false},{"id":21508,"name":"Dennis Wylie","orcid":"0000-0003-0380-3549","position":17,"is_corresponding":false},{"id":105934,"name":"Jennifer A. Maynard","orcid":"0000-0002-0363-8486","position":18,"is_corresponding":false},{"id":236814,"name":"Lauren I. R. Ehrlich","orcid":"0000-0002-1697-1755","position":19,"is_corresponding":false},{"id":490960,"name":"Esther Melamed","orcid":"0000-0001-5571-3591","position":20,"is_corresponding":false},{"id":1196336,"name":"Nadia Siles","orcid":"0009-0000-1506-6123","position":0,"is_corresponding":true}],"reference_count":38,"raw_metadata":{"citation_network_status":"fetched"},"created_at":"2026-07-19T01:22:05.177070Z","pmid":"38106077","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}